Subscribe to Newsletter
Business & Profession Professional Development, Business and Innovation

Business in Brief

  • Beaver-Visitec International are to acquire the single-use ophthalmic instrument manufacturer, Malosa Medical.
  • According to Bloomberg, Novartis are rumored to have hired Bank of America for an Alcon business review – and may pursue a spinoff, with Novartis’ CEO Joe Jimenez quoted saying that the business is worth “$25–35 billion.”
  • Novartis have also licensed ECF843, a recombinant human lubricin, from Lubris LLC. Lubricin deficiency is observed in many patients with dry eye.
  • Alcon announced the EU launch of its CyPass micro-stent MIGS device, which is indicated for the treatment of patients with mild-to-moderate primary open-angle glaucoma (POAG) in conjunction with cataract surgery, or as a standalone procedure in patients with POAG who have failed previous medical treatments.
  • Heidelberg Engineering (HE) acquired UK-based electronic medical records firm, Medisoft Limited, adding to its ophthalmic IT offerings. Medisoft will retain their UK headquarters, and HE’s Arianna Schoess and Kfir Azoulay have joined Medisoft’s board of directors.
  • Allergan and Argentum have reached an agreement to settle a patent dispute over Restasis. The agreement gives Argentum the right to sell a generic version of Restasis before Allergan’s patents on the drug expire.
  • Imprimis licenses the Richard Lindstrom-developed chondroitin sulfate-containing topical dry eye treatment, Klarity eye drops.
Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Most Popular
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine



The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: